Faculty Disclosures
In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.
Joint Accreditation/ACCME also requires that ADCES mitigate any reported conflict and eliminate the potential for bias during the educational activity. The disclosure information is intended to identify any ineligible relationships and allow learners to form their own judgments. However, if you perceive a bias during an activity, please report it on the evaluation.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:
Speakers
Anders Carlson, MD: Abbott Diabetes: Research (Ongoing); Dexcom: Research (Ongoing); Eli Lilly: Research Grant (Ongoing); Insulet: Consultant (Ongoing), Research (Ongoing); Luna: Research (Ongoing); MannKind: Consultant (Ongoing); Medtronic: Consultant (Ongoing), Research (Ongoing); Novo Nordisk: Consultant (Ongoing), Research (Ongoing); Sanofi: Research (Ongoing); Tandem: Research Grant (Ongoing); Zealand: Research Grant (Ongoing)
Planners
Cari Berget, RN, MPH, CDCES - Insulet Corporation, Tandem (Consultant); Insulet Corporation, Embecta (Speakers bureau)
Davida Kruger, MSN, APN-BC, BC-ADM – Abbott, Tandem, Insulet Sequel (Research); Abbott Diabetes CeQur Lilly MannKind Medtronics Ascentia Insulet (Consultant); Dexcom, CeQur, Lilly, Novo, Abbott, Tandem, Insulet, Sequel (Speaker/honoraria)
Natalie J. Bellini, APRN, RN, BC-ADM - Abbott Diabetes Eli Lilly Co, Medtronic Diabetes, Sanofi aventis, Sequel Medical Technology (Speaker/Honoraria)
Emily Boranian, RN, CDCES - No financial relationships to disclose
Amy Butts, PA, BC-ADM, CDCES – Abbott (consultant); Abbott, Novo Nordisk, Corcept, Xeris (speakers bureau)
Angela Gonzalez, FNP – No financial relationships to disclose
Celia Levesque, APRN, BC-ADM, CDCES, CNS, NP, RN - No financial relationships to disclose
Caitlin Nass, MSN, NP – Dexcom (speakers bureau); Sanofi (presenter, advisory panel), Corcept (presenter, advisory panel)
Lucia Novak, MSN, ANP-BC, BC-ADM - Abbott, Nestle,Novo, Sanofi (speakers bureau)
Sean Oser, MD, MPH - Ascensia (Consultant / Advisory Board Terminated, January 20, 2024) Dexcom (Consultant / Advisory Board); Sequel, Abbott, Dexcom, Insulet (Research)
Linda Parks, MS, RN CDCES – Glucotrack (consultant relationship ended) Glooko (stock)
Dana Roseman, MPH, RD, RDN – No financial relationships to disclose
Morgan Stewart, PharmD, BCACP, BC-ADM - Abbott Laboratories: Received 72 no-cost sensors for research project/educational wear experience; Dexcom, Inc: Received 185 no cost sensors to use for educational wear experience for research projects
Becky Sulik, CDCES, LD, RD – Insulet, Medtronic, Tandem, and BetaBionics (Pump Trainer); Sanofi (speaker board); Insult, Medtronic, BetaBionics (Speaker honorarium)
Angela Thompson, DNP, APRN, FNP-C, BC-ADM, CDCES, FAANP Tandem Diabetes (12/24 received travel funds)
Sara Wettergreen, PharmD – No financial relationships to disclose
Paulina Duker, MPH, RN, CDCES, FADCES – No financial relationships to disclose
Autumn Zarlengo - No financial relationships to disclose
Disclosure and Mitigation of Relevant Conflicts of Interest
All identified relevant conflicts of interest have been mitigated.
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.